💞 #Gate Square Qixi Celebration# 💞
Couples showcase love / Singles celebrate self-love — gifts for everyone this Qixi!
📅 Event Period
August 26 — August 31, 2025
✨ How to Participate
Romantic Teams 💑
Form a “Heartbeat Squad” with one friend and submit the registration form 👉 https://www.gate.com/questionnaire/7012
Post original content on Gate Square (images, videos, hand-drawn art, digital creations, or copywriting) featuring Qixi romance + Gate elements. Include the hashtag #GateSquareQixiCelebration#
The top 5 squads with the highest total posts will win a Valentine's Day Gift Box + $1
Hang Likang: Currently, there is only one innovative drug project under research.
Jin10 Data July 1st, Anglikon released an announcement regarding abnormal fluctuations in stock trading. The company has noticed that the market's attention on innovative drug business has been relatively high recently. Currently, the company has only one innovative drug project under research, which is the ALK-N001 project. This project received a notice of approval for clinical trials in April 2025, and as of the date of this announcement, it is still in the Phase I clinical trial stage. The development of innovative drugs is characterized by long cycles, high investment, and high uncertainty, and investors are advised to pay attention to investment risks.